Page 11 - IPO Tracker

Corona Remedies IPO opens Dec 8: Bid or skip? Here's what experts suggest

Corona Remedies IPO Date: The unlisted shares of Corona Remedies were trading at ₹1,427, commanding a grey market premium of ₹365 or 34.4 per cent on Friday

Park Medi World IPO opens Dec 10; sets price band at ₹154-162: Key details

Park Medi World is eyeing ₹770 crore through the fresh issue for 47.5 million equity shares, and shareholders will be selling 9.3 million equity shares through an OFS for ₹150 crore

Manipal Health readies $1 bn IPO; targets $12-15 bn valuation

Valuation of India's largest hospital network is around $12-15 bn. The Issue will comprise fresh issue of shares and a small portion as OFS

NephroPlus plans global scale-up ahead of IPO amid rising CKD burden

India's largest dialysis provider plans to expand clinics at home and abroad ahead of its December 10 IPO, betting on rising CKD burden and demand for accessible dialysis care

Corona Remedies IPO opens Dec 8: GMP at 31%; 5 key risks you should know

Corona Remedies IPO will be offered at a price band of ₹1,008 to ₹1,062 per share, with a lot size of 14 shares

Meesho IPO booked 3x on strong demand; should you bid too? Analysts weigh

Analysts highlight Meesho's zero-commission, asset-light business model, coupled with its multi-sided marketplace and logistics network

Nephrocare Health sets IPO price band at ₹438-460: Check key details here

Nephrocare Health IPO will open for public subscription on Wednesday, December 10 and close on Friday, December 12

Meesho IPO subscribed 2.4 times on day one; retail book nearly four times

Meesho's IPO was subscribed 2.4 times on the first day, driven by strong retail demand, after it raised Rs 2,440 crore from anchors and set a price band of Rs 105-111 per share

Corona Remedies bets on female hormone complex generics ahead of IPO

Corona Remedies is pushing into female hormone complex generics to expand beyond India, as its Rs 655.3-crore OFS IPO opens December 8, with a new hormone plant and a stake in La Chandra Pharma Labs

IGX board approves plan for IPO to raise funds, no details about offer size

However the Indian Energy Exchange (IEX) did not divulge details about the size of the issue, opportune time and the modalities of the issue

Wakefit IPO: D2C growth story, key risks ahead, what investors should know

According to the RHP, Wakefit's performance is heavily dependent on its "Wakefit" brand, under which it sells mattresses, furniture and home furnishings

Retail investors drive demand for Aequs IPO on Day 1, NIIs follow; QIBs lag

Retail investors have oversubscribed their reserved portion by 6.42 times, while non-institutional investors (NIIs) have closely followed, with their segment oversubscribed by 1.45 times

Vidya Wires IPO fully subscribed: Retail investors lead demand; GMP at 12%

Vidya Wires IPO Day 1 update: Retail individual investors (RIIs) led the response, subscribing to their allocated portion 1.86 times

Corona Remedies IPO price band at ₹1,008-1,062; check dates, GMP, objective

Corona Remedies aims to raise ₹655.37 crore through an offer for sale of 6.2 million equity shares

Meesho vs Aequs vs Vidya Wires IPO: Which one should you bet on?

Analysts remain largely positive on Meesho IPO and Vidya Wires IPO, citing strong growth prospects and operational efficiency, while views on Aequs IPO are cautious

Meesho IPO opens: From price band to GMP, here's all you need to know

Meesho IPO opens today: Check price band, lot size, GMP, review, allotment date, listing date and other key details here

Indian ecom penetration could mirror WhatsApp user base: Meesho cofounder

Meesho Cofounder Sanjeev Kumar says India's ecommerce penetration could eventually match Whatsapp's vast user base, driven by rapid growth in smaller cities and heavy investment in AI and tech

Debt repayment, capital expenditure: How IPO proceeds are being utilised

data on 189 IPOs where information is available show that the total amount to be raised through fresh equity was Rs 1.20 trillion, with another offer for sale (OFS) component being Rs 62,000 crore

Willing to apply for Meesho IPO? Check these key risks, strengths from RHP

Investors willing to apply for Meesho IPO can review the company's strengths and risks as outlined in its Red Herring Prospectus (RHP)

Vidya Wires IPO opens tomorrow: Bid or skip? Here's what experts suggest

The unlisted shares of Vidya Wires were trading at ₹57, commanding a grey market premium of ₹5 or 9.6 per cent on Tuesday